Perhaps there has always been an uneasy relationship between science and the law. Though Daubert ostensibly governs the use of scientific evidence in litigation in most, if not all, jurisdictions, use of the Daubert procedures has not lead to uniform results nor consistent fairness. Astonishing developments in genomic research now stretch the ability of the law to put new scientific evidence into use and of both the regulated communities and private citizens to understand and respond to it. This article is a very brief survey of some of the many areas where genomic information may change the way evidence is presented and understood and also the way the use of this information may apply to a few of the varied and disparate parts of our lives.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]